scispace - formally typeset
S

Sheng-Fung Lin

Researcher at Kaohsiung Medical University

Publications -  133
Citations -  2781

Sheng-Fung Lin is an academic researcher from Kaohsiung Medical University. The author has contributed to research in topics: Myeloid leukemia & Leukemia. The author has an hindex of 26, co-authored 130 publications receiving 2513 citations. Previous affiliations of Sheng-Fung Lin include I-Shou University & Fooyin University.

Papers
More filters
Journal ArticleDOI

Altered expression of SIRT gene family in head and neck squamous cell carcinoma

TL;DR: Real-time quantitative reverse transcription-polymerase chain reaction is used to investigate the expressions of the seven SIRT genes in human HNSCC tissues to assess the changes in cancerous and noncancerous parts and the correlation with different tumor behaviors and indicates that Sirt genes expression could help in the diagnosis and represent a prognostic biomarker in H NSCC.
Journal ArticleDOI

Disturbance of circadian gene expression in hepatocellular carcinoma.

TL;DR: Downregulation of circadian genes results in disturbance of circadian rhythm in hepatocellular carcinoma which may disrupt the control of the central pacemaker and benefit selective survival of cancerous cells and promote carcinogenesis.
Journal ArticleDOI

MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.

TL;DR: MALAT1 was overexpressed in patients with myeloma and may play a role in its pathogenesis and in addition, MALAT1 may serve as a molecular predictor of early progression.
Journal ArticleDOI

Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3.

TL;DR: The results suggest that the downregulated hPER3 expression in CML is correlated with the inactivation of hPER2 by methylation, and the methylated CpG frequencies differed significantly in patients at blastic crisis and at chronic phase.
Journal ArticleDOI

Abnormal expression of period 1 (PER1) in endometrial carcinoma

TL;DR: The results suggest that down‐regulation of the PER1 gene disrupts the circadian rhythm, which may favour the survival of endometrial cancer cells.